Cervicogenic Headache Dose-Response

NCT01530321 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
256
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Western States

Collaborators